Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. H. Aardema


Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients

Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations

Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study

Prevention and treatment of infections in intensive care patients: Challenges and potential improvements

Changes in gut microbiota in cardiac surgery patients before, during and after admission to the intensive care unit: a prospective cohort study

Influenza-associated Aspergillosis in Critically III Patients

Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: A prospective observational study

Burden of highly resistant microorganisms in a Dutch intensive care unit

Augmented Renal Clearance in Critically Ill: Advantage or Threat

Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.

Read more